Who owns Virtus Biotech Clinical Trials ETF?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of BBC from SEC Form 13F filings across 21 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 21 institutions disclosed 377,242 shares of Virtus Biotech Clinical Trials ETF worth $19.9M — about 39.7% of shares outstanding; the largest disclosed holder is Kera Capital Partners, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
21
13F holders
$19.9M
value, 2026 filers
39.7%
of shares outstanding (377,242 sh)
8
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of BBC's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Kera Capital Partners, Inc. | 101,003 | $5.3M | 0.5% | 10.6% | +13.0% |
| 2 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLCNEW | 68,536 | $3.6M | 0.0% | 7.2% | new |
| 3 | Militia Capital Management LLC | 45,663 | $2.4M | 0.1% | 4.8% | 0.0% |
| 4 | CITADEL ADVISORS LLC | 42,736 | $2.3M | 0.0% | 4.5% | +52.2% |
| 5 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 38,960 | $2.1M | 0.0% | 4.1% | -25.2% |
| 6 | Quantinno Capital Management LP | 23,009 | $1.2M | 0.0% | 2.4% | +18.7% |
| 7 | MORGAN STANLEY | 15,026 | $791,664 | 0.0% | 1.6% | -1.4% |
| 8 | LPL Financial LLC | 12,329 | $649,567 | 0.0% | 1.3% | -0.8% |
| 9 | GOLDMAN SACHS GROUP INCNEW | 8,674 | $456,999 | 0.0% | 0.9% | new |
| 10 | OSAIC HOLDINGS, INC. | 4,463 | $235,175 | 0.0% | 0.5% | +489.6% |
| 11 | ENVESTNET ASSET MANAGEMENT INCNEW | 4,448 | $234,348 | 0.0% | 0.5% | new |
| 12 | Worth Asset Management, LLCNEW | 4,093 | $215,644 | 0.1% | 0.4% | new |
| 13 | Operose Advisors LLCNEW | 2,274 | $119,808 | 0.0% | 0.2% | new |
| 14 | UBS Group AG | 2,096 | $110,430 | 0.0% | 0.2% | +1441.2% |
| 15 | Institute for Wealth Management, LLC.NEW | 1,890 | $99,577 | 0.0% | 0.2% | new |
| 16 | Dynamic Wealth Strategies, LLC | 927 | $48,840 | 0.0% | 0.1% | 0.0% |
| 17 | COMPASS FINANCIAL MANAGEMENT LLCNEW | 545 | $28,533 | 0.0% | 0.1% | new |
| 18 | GROUP ONE TRADING LLC | 300 | $15,806 | 0.0% | 0% | 0.0% |
| 19 | MERCER GLOBAL ADVISORS INC /ADVNEW | 150 | $7,903 | 0.0% | 0% | new |
| 20 | Federation des caisses Desjardins du Quebec | 110 | $5,795 | 0.0% | 0% | 0.0% |
| 21 | Allworth Financial LP | 10 | $527 | 0.0% | 0% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.